Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

J. M. Connors, W. Jurczak, D. J. Straus, S. M. Ansell, W. S. Kim, A. Gallamini, A. Younes, S. Alekseev, A. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. J. Savage, N. L. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P. L. ZinzaniD. Cunningham, A. Rosta, N. C. Josephson, E. Song, J. Sachs, R. Liu, H. A. Jolin, D. Huebner, J. Radford

Research output: Contribution to journalArticlepeer-review

561 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry